AWS launches Amazon Bio Discovery to accelerate AI-powered research in life sciences
A new agentic AI application aims to speed up drug development, helping bring new medical treatments to patients faster.
Key takeaways
- AI-powered application assisting scientists with drug design paired with lab testing creates a loop where each experiment improves the next.
- Scientists can access leading AI models, view benchmarks, and use an AI agent to guide experiments.
- The application is designed to make AI models more accessible to scientists, not just those with AI and coding skills.
- With Memorial Sloan Kettering, the application accelerated antibody design for potential pediatric cancer therapies from months to weeks.
Today, AWS announced Amazon Bio Discovery, a new AI-powered application designed to help scientists design and test novel drugs more quickly and confidently.
Amazon Bio Discovery gives scientists direct access to a broad catalog of specialized AI models called biological foundation models (bioFMs) that are trained on vast biological datasets. These models generate and evaluate potential drug molecules, known as candidates, helping scientists accelerate antibody therapies during the early stages of drug discovery. But access alone is not enough.
